High-dose methotrexate as CNS prophylaxis in DLBCL
Kate Cwynarski, MD, PhD, University College Hospital, London, UK, discusses data from a multicenter analysis evaluating the impact high-dose methotrexate as CNS prophylaxis in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
▶︎
R-CHOP Chemotherapy & Dealing with Side Effects | Luis’ Story (2 of 3) | The Patient Story
▶︎
Managing High-Dose Methotrexate Toxicity
▶︎
Primary CNS Lymphoma An Overview of Management & Highlight of Advances - Joe Mendez, M.D.
▶︎
Is CNS prophylaxis warranted in DLBCL?
▶︎
CNS relapse in DLBCL: risk stratification, prophylaxis & treatment
▶︎
QD46 - When To Stop MTX
▶︎
She’s 12. She Sings Aretha Franklin… Until Simon TELLS Her to Do It Acapella! 😳
▶︎
I Used 100% CASTOR OIL Eye Drops for 30 days - Here's What happened
▶︎
Colin Farrell Opens Up About His Son With Angelman Syndrome | PEOPLE
▶︎
Methotrexate (Rheumatoid Arthritis Drug)
▶︎
Consolidation strategies for CNS lymphoma
▶︎
Diffuse Large B-Cell Lymphoma (DLBCL) - Aggressive B-Cell Neoplasm - Non-Hodgkin’s Lymphoma
▶︎
Primary Central Nervous System Lymphoma
▶︎
Managing High-Dose Methotrexate Infusions
▶︎
Understanding Diffuse Large B-Cell Lymphoma with Jennifer Amengual, MD
▶︎
The prognostic significance and therapeutic potential of the TLR 7/8 pathway in CNS lymphomas
▶︎
What a Stroke Looks Like the Day Before It Hits — Know This to Protect Yourself
▶︎
Large B cell lymphoma CNS prophylaxis and CNS involvement Management Dr Andres Ferreri
▶︎
BIG UPDATE: Final Methotrexate Chemo Done!
▶︎